BPG is committed to discovery and dissemination of knowledge
Featured Articles
12/10/2020 10:32:41 AM | Browse: 521 | Download: 2213
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 57893
Country China
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Noncommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Retrospective Study
Article Title Clinicopathological characteristics and prognosis of 77 cases with type 3 gastric neuroendocrine tumours
Manuscript Source Unsolicited Manuscript
All Author List Yuan-Liang Li, Xu-Dong Qiu, Jie Chen, Yu Zhang, Jie Li, Jian-Ming Xu, Chao Wang, Zhi-Rong Qi, Jie Luo and Huang-Ying Tan
Funding Agency and Grant Number
Funding Agency Grant Number
National Natural Science Foundation of China 81673763
Foundation of Guangzhou Science and Technology Plan 201804010078
Corresponding Author Huang-Ying Tan, MD, PhD, Professor, Department of Integrative Oncology, China-Japan Friendship Hospital, No. 2 Yinghuadong Street, Beijing 100029, China. tanhuangying@263.net
Key Words Type 3 gastric neuroendocrine tumours; Clinicopathological characteristics; Endoscopic treatment; Prognosis; Chinese population;
Core Tip Type 3 gastric neuroendocrine tumours (g-NETs) were heterogeneous based on 2019 WHO pathological classification. Endoscopic treatment was safe and effective for patients with G1 NETs having tumours under 2 cm, confined to the mucosa or submucosa. The prognosis of type 3 g-NETs was related to stage and grade, which were its independent prognostic factors, and 2019 WHO pathological classification was effective to predict its biological behaviors and prognosis.
Publish Date 2020-12-10 10:17
Citation Li YL, Qiu XD, Chen J, Zhang Y, Li J, Xu JM, Wang C, Qi ZR, Luo J, Tan HY. Clinicopathological characteristics and prognosis of 77 cases with type 3 gastric neuroendocrine tumours. World J Gastrointest Oncol 2020; 12(12): 1416-1427
URL https://www.wjgnet.com/1948-5204/full/v12/i12/1416.htm
DOI https://dx.doi.org/10.4251/wjgo.v12.i12.1416
Full Article (PDF) WJGO-12-1416.pdf
Full Article (Word) WJGO-12-1416.docx